Form 4 Tracker
Entrada Therapeutics, Inc.
TRDA

33 insider filings · Latest: Sep 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 17, 2025Mar 17 8:32 PMKORY WENTWORTH
Proposed Sale
1,784$10.81$19.3K—

View →

Nov 11, 2024Nov 12 12:54 PMNATARAJAN SETHURAMAN
Proposed Sale
18,762$19.82$371.9K—

View →

Nov 11, 2024Nov 12 12:53 PMKORY WENTWORTH
Proposed Sale
14,637$19.82$290.1K—

View →

Oct 16, 2024Oct 16 8:25 PMNATARAJAN SETHURAMAN
Proposed Sale
20,057$17.53$351.6K—

View →

Sep 9, 2024Sep 9 8:27 PMKORY WENTWORTH
Proposed Sale
3,195$14.80$47.3K—

View →

Sep 6, 2024Sep 6 8:19 PMNATHAN DOWDEN
Proposed Sale
3,150$15.39$48.5K—

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 10, 2026Jun 12 9:34 PMKush ParmarDirector, 10% Owner
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 9:17 PMPeter S KimDirector
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 9:16 PMGina ChapmanDirector
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 9:05 PMMaha RadhakrishnanDirector
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 9:01 PMMary ThistleDirector
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 8:52 PMBernhardt G ZeiherDirector
Grant/Award
19,000$5.9719,000(D)

View →

May 4, 2026May 4 11:24 PMNathan J DowdenPresident & COO
Option Exercise
15,000$1.7449,831(D)

View →

Mar 1, 2026Mar 3 11:21 PMDipal DoshiDirector, CEO
Grant/Award
208,000$11.93208,000(D)

View →

Mar 1, 2026Mar 3 11:20 PMKory James WentworthChief Financial Officer
Grant/Award
66,600$11.9366,600(D)

View →

Mar 1, 2026Mar 3 11:19 PMNathan J DowdenPresident & COO
Grant/Award
83,200$11.9383,200(D)

View →

Mar 1, 2026Mar 3 11:18 PMNatarajan SethuramanPresident, Research & Develop.
Grant/Award
83,200$11.9383,200(D)

View →